Sort
130,381 grants matching “hiv”
Manipulating Epigenetic Control Mechanisms to Control HIV Transcription
$777,150Jonathan Karn · Case Western Reserve University · DP1 · FY2010 · DA
Ending the HIV Epidemic in Rural America (EHE-RA): Local Interventions, Co-Epidemics, and Social Determinants
$777,144Anthony Todd Fojo · Johns Hopkins University · R01 · FY2025 · MD
COST EFFECTIVE TREATMENT FOR DUALLY DIAGNOSED HOMELESS
$777,142University Of Alabama At Birmingham · R01 · FY2004 · DA
Motivating HIV+ Women: Risk Reduction and ART Adherence
$777,139Emory University · R01 · FY2005 · NR
Los Angeles Pediatric AIDS Clinical Trials Unit
$777,136Yvonne J Bryson · University Of California Los Angeles · U01 · FY2006 · AI
Integrated analysis of CVD risk in HIV: gut microbiota, immune function and metabolites
$777,067Qibin Qi · Albert Einstein College Of Medicine · R01 · FY2021 · HL
Evaluating Demand Generation (Stylish Man) for HIV/Family Planning Services Rakai
$777,065Maria J Wawer · Johns Hopkins University · R01 · FY2015 · AI
Vaccine Synergy through Synchronous Delivery
$777,061Michael A Barry · Mayo Clinic Rochester · R01 · FY2018 · AI
Immunity to novel T/F SHIVs: variability in the co-evolution of virus and host immunity
$777,026Garnett H Kelsoe · Duke University · R01 · FY2021 · AI
Impact of the gastrointestinal microbiome on HIV reservoirs
$777,023Angela Raquel Wahl · Univ Of North Carolina Chapel Hill · R01 · FY2021 · DK
Impact of the gastrointestinal microbiome on HIV reservoirs
$777,023Angela Raquel Wahl · Univ Of North Carolina Chapel Hill · R01 · FY2022 · DK
A Rapid Point-of-Care Test to Improve ART and PrEP Adherence
$777,019Paul K Drain · University Of Washington · R01 · FY2019 · AI
Simple and rapid POC detection for fungemia
$777,001David Alland · Rbhs-New Jersey Medical School · R01 · FY2021 · AI
INHIBITION OF MYOCOLIC ACID BIOSYNTHESIS--M.TUBERCULOSIS
$776,978Yeshiva University · R01 · FY2002 · AI
Contribution of anti-env immune responses to protection by live attenuated SIV
$776,974Ronald C Desrosiers · Harvard Medical School · P01 · FY2008 · AI
Low-Cost Instrument-free Point-of-Care Diagnostic for Neisseria gonorrhoeae
$776,968Debkishore Mitra · Lucira Health, Inc · R44 · FY2018 · AI
New Strategy to Improve Gastrointestinal Health in SIV/HIV
$776,963Cristian Apetrei · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Promoting remote and secondary risk prevention services in rural settings
$776,927Mai Tuyet Pho · University Of Chicago · R01 · FY2025 · DA
Impact of HIV/SIV Infection on Paneth and Intestinal Stem Cell Interaction
$776,923Bapi Pahar · Tulane University Of Louisiana · R01 · FY2019 · DK
Impact of HIV/SIV Infection on Paneth and Intestinal Stem Cell Interaction
$776,916Pete J Didier · Tulane University Of Louisiana · R01 · FY2020 · DK
ADMINISTRATIVE AND TECHNICAL SUPPORT FOR HIV LAB ACTIVITIES IN BRAZIL
$776,900Rodrigo De Mora Brindeiro · Fundacao Universitaria Jose Bonifacio · U62 · FY2006 · PS
Wastewater Sampling: A New Tool to Accelerate Ending the HIV Epidemic
$776,846Thomas P Giordano · Baylor College Of Medicine · R01 · FY2023 · DA
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection
$776,825Neel Rajnikant Gandhi · Emory University · R01 · FY2022 · AI
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)
$776,744Marco Salemi · University Of Florida · R01 · FY2022 · AI
NOVEL ASSAYS FOR MEASURING THE INHIBITION OF VIRUS ENTRY
$776,731Monogram Biosciences, Inc. · R44 · FY2005 · AI